Darktrace, the world’s leading cyber AI company, announced that its AI-powered email security technology, Antigena Email, has been selected as Application Security Winner in the 2020 Fortress Cyber Security Awards, hosted by the Business Intelligence Group.
News
Anglia Ruskin University (ARU) has been named as one of the top 10 mainstream universities in the country for graduate employment.
25-06-2020
Thanks to a ‘virtual road-trip’ which went live this week, people can have their say on the shortlist of options being considered to improve the Ely-Cambridge stretch of the A10, despite Covid-19 safeguards restricting public gatherings.
25-06-2020
Siemens has signed an agreement to acquire Cambridge, UK-based UltraSoC Technologies Ltd., a provider of instrumentation and analytics solutions that put intelligent monitoring, cybersecurity and functional safety capabilities into the core hardware of system-on-chip (SoC).
25-06-2020
Calling all technology companies! Apply now for Deloitte’s prestigious Technology Fast 50 awards programme.
25-06-2020
A new initiative at Cambridge will equip young researchers outside computer science with the skills they need to use machine learning and artificial intelligence techniques to power their research.
25-06-2020
8power is pleased to announce that it has completed a successful remote condition monitoring trial with Anglian Water. The trial used sensors and analytic services on some large water pumping assets.
25-06-2020
With agriculture accounting for 70% of water consumption globally, huge impact can be made with technology adoption by the industry. AgriTech is stepping up to bat.
25-06-2020
From March 2020 to May 2020, East Anglia saw the fourth driest period since records began in 1892.
25-06-2020
Problems in how the brain recognizes and processes novel information lie at the root of psychosis, researchers from the University of Cambridge and King’s College London have found. Their discovery that defective brain signals in patients with psychosis could be altered with medication paves the way for new treatments for the disease.
25-06-2020
Resolution has announced that Juliet Harvey, Legal Director and Chartered Legal Executive in Birketts’ Family Team, has been elevated to National Chair.
25-06-2020
Cambridge law firm Stone King is running a series of free workshops in July designed to offer insight into various aspects of immigration sponsorship for a range of organisations, in particular charities, the education sector and religious orders.
25-06-2020
Biocair will transport selected blood samples to specialist laboratories for investigation to find out if an individual has developed antibodies against the SARS-CoV-2 virus.
25-06-2020
Cambridge residents can join in with a virtual programme of talks, performance, demonstrations, articles, films and more during June and July, for the first ever Cambridge South Asian History Month.
25-06-2020
In the current climate, there are many landlords that will not receive payment of the June quarter's rent and many who also did not receive payment of the rent due in March. Susanne Hinde of Hewitsons discusses the issues.
24-06-2020
Do you use a hearing aid or find yourself hard-of-hearing...or does someone in your family? If so, Cambridgeshire Hearing Help (CHH) is setting up a new online social group - just for you!
24-06-2020
Find out more about health research at NIHR Cambridge Biomedical Research Centre and how you can get involved.
24-06-2020
Chris Dunn Consulting supported Electrolux Business Area Europe to complete an exciting transformation that put the consumer at the heart of their aftermarket operations.
24-06-2020
Testing for coronavirus infection could become quicker, more convenient and more accurate, following the launch of a multicentre national programme of research that will evaluate how new diagnostic tests perform in hospitals, general practices and care homes.
24-06-2020
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta’s partners at Cytiva (formerly GE Healthcare Life Sciences) and show positive initial performance data.
24-06-2020
Pages
